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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYInactivation of the Pancreatic and Duodenal Homeobox 1 (PDX1) gene causes pancreatic agenesis, which places PDX1 high atop the
regulatory network controlling development of this indispensable organ. However, little is known about the identity of PDX1 transcrip-
tional targets. We simulated pancreatic development by differentiating human embryonic stem cells (hESCs) into early pancreatic pro-
genitors and subjected this cell population to PDX1 chromatin immunoprecipitation sequencing (ChIP-seq). We identified more than
350 genes bound by PDX1, whose expression was upregulated on day 17 of differentiation. This group included known PDX1 targets
andmany genes not previously linked to pancreatic development. ChIP-seq also revealed PDX1 occupancy at hepatic genes.We hypoth-
esized that simultaneous PDX1-driven activation of pancreatic and repression of hepatic programs underlie early divergence between
pancreas and liver. In HepG2 cells and differentiating hESCs, we found that PDX1 binds and suppresses expression of endogenous liver
genes. These findings rebrand PDX1 as a context-dependent transcriptional repressor and activator within the same cell type.INTRODUCTION
The adult pancreas is comprised of two major functional
compartments. The endocrine pancreas contains hor-
mone-secreting cells, with the glucose-sensing, insulin-
secreting b cells garnering tremendous clinical attention
for their role in the pathology of diabetes. The exocrine
pancreas contains digestive enzyme-secreting acinar cells
and ductal epithelial cells that produce mucin and plumb
the pancreas, providing transport channels for the secre-
tion of acinar enzymes into the duodenum. All of these tis-
sues originate embryonically from the definitive endoderm
(DE), one of the three primary germ layers formed during
gastrulation (reviewed extensively in Pan and Wright,
2011; Shih et al., 2013).
By embryonic day (E) 8.5 in the mouse embryo, the DE
forms a sheet of simple squamous epithelium lining the
ventral surface of the lordotic embryo. Anteriorly, a special-
izedpit termed theanterior intestinal portal (AIP) forms and
its continued invagination results in a pocket—the fore-
gut—whose descendants give rise to the esophagus, lungs,
thyroid, liver, pancreas, and biliary system. Morphologi-
cally, the incipient pancreas is recognizable as dorsal and
ventral evaginationsonopposing sides of theposterior fore-
gut around E9.5. At this stage, the pancreatic primordium is
conspicuously labeled by the expression of the ParaHox
gene Pancreatic and Duodenal Homeobox 1 (Pdx1) (Ahlgren578 Stem Cell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Authoet al., 1996; Guz et al., 1995; Jørgensen et al., 2007; Offield
et al., 1996). Lineage tracing experiments show that these
early Pdx1+ cells are multipotent, giving rise to all three
components of the mature pancreas (Gannon et al., 2000;
Gu et al., 2002). Loss-of-function studies further demon-
strate that Pdx1 is not only an indelible marker of the early
pancreatic lineagebut also is required cell autonomously for
early pancreas formation (Ahlgren et al., 1996; Jonsson
et al., 1994; Offield et al., 1996). In Pdx1 null mutant em-
bryos, patent dorsal and ventral buds form but quickly
regress, resulting in pancreatic agenesis, severe postnatal
hyperglycemia, and eventual death. PDX1 is similarly ex-
pressed in the developing human pancreas (Jennings
et al., 2013), and in 1997, a case of rare human pancreatic
agenesis was reported in an individual homozygous for a
cytosine deletion in codon 63 of PDX1 (Pro63fsdelC)
(Stoffers et al., 1997b). This result underscores why PDX1
activation is considered an obligatory mile marker for the
successful in vitro production of therapeutically relevant b
cells from pluripotent human stem cells.
Despite the central role of Pdx1/PDX1 in orchestrating
pancreatic morphogenesis in mice and humans, vanish-
ingly little is known about its direct transcriptional
targets. Here, we chose to address this deficit by devel-
oping an in vitro human embryonic stem cell (hESC)
differentiation protocol that specifically captures robust
numbers of early multipotent, proliferative PDX1+rs
pancreatic progenitor (ePP) cells. Based on extensive mo-
lecular marker analysis, ePP cells on day 17 of differentia-
tion strongly resemble the early mammalian dorsal and
ventral pancreatic buds. We therefore performed chro-
matin immunoprecipitation followed by massively paral-
lel DNA sequencing (ChIP-seq) in an effort to elaborate
the pancreatic gene regulatory network over which
PDX1 presides. Our analyses identified more than 350
genes who are simultaneously bound by PDX1 (within ±
20 kb of the transcriptional start site [TSS]) and whose
expression is upregulated on day 17 of differentiation.
We also unexpectedly found that PDX1 binds classic liver
marker genes such as ALB, AFP, and TTR, which label hep-
atoblasts, the precursors to hepatocytes, in the developing
mammalian embryo. This result suggested that acquisi-
tion of pancreatic identity requires direct and simulta-
neous suppression of the liver transcriptional program
by PDX1. We tested this hypothesis by transiently overex-
pressing PDX1 in HepG2 cells and by constitutively over-
expressing PDX1 in hESCs and confirmed that PDX1 can
indeed bind and repress a battery of hepatic genes. These
results provide fundamental insight into how organ-
specific transcriptional programs are established during
embryonic development and recast PDX1 as both a tran-
scriptional activator and repressor.RESULTS
Early Pancreatic Progenitor Cells from Differentiated
hESCs
We previously reported the production of ePP cells from
the differentiation of hESCs in adherent culture (Teo
et al., 2012). These ePP cells were characterized by high
levels of PDX1 expression on day 12, but quantitation by
fluorescence-activated cell sorting (FACS) revealed that
they numbered no more than 35% of the entire culture.
We therefore explored other culture methodologies and
platforms aimed at improving differentiation efficiency
to ePP and discovered that PDX1+ cell numbers were
increased substantially by initially plating hESC on fibro-
nectin-coated transwell dishes and by extending retinoic
acid (RA) treatment by 2 days and supplementing with
FGF2, nicotinamide, and DAPT (FND) (see Figure 1A). On
day 14, FND was replenished, and cultures were typically
harvested on day 17 (Figure 1A). In this revised protocol,
hESCs expectedly form a cobblestone-like lawn of DE cells
by day 5 (Figure 1A). By day 10, distinct cell clusters emerge
and shortly thereafter appear to undergo microlumen
formation and fusion reminiscent of the tubulogenesis
that occurs in vivo in the developing mouse pancreas (Fig-
ure 1A) (Kesavan et al., 2009; Villasenor et al., 2010). With
continued differentiation, thickened ridges extend andStemintersect across the transwell in a honeycomb-like mesh-
work (Figure 1A).
To determine how faithfully ePP production in transwell
culture followed the normal program of organogenesis,
we used qRT-PCR to examine the expression of a panel of
signaturemarker genes from days 0 to 17 of differentiation.
These analyses document the transition from pluripotency
to mesendoderm, which was characterized by the downre-
gulation of pluripotency genes NANOG, OCT4, and SOX2
and the upregulation of BRACHYURY (T), GOOSECOID,
MIXL1, and EOMES (Figure S1A). This event was followed
shortly thereafter by upregulation of pan-DE (GATA4,
CXCR4, SOX17, FOXA2, GATA6), ventral DE (HHEX), and
gut tube (HNF1B) marker genes (Figures 1B and S1A). Be-
tween days 5 and 17, dorsal endoderm (ISL1, MNX1) and
posterior foregut/pancreatic progenitor (SOX9, PDX1,
HNF6, NKX6-2, HNF1A, SOX4) markers were increasingly
expressed (Figures 1B and S1A). Western blot analyses on
differentiated hESC from days 0 to 17 confirmed the tran-
sition from DE (SOX17, FOXA2) to pancreatic epithelial
progenitors (SOX9, PDX1, E-CAD) (Figure S1B). Immuno-
detection analyses further showed abundant FOXA2-,
HNF1B-, SOX9-, or E-CAD-positive cells on day 10 (Fig-
ure 1C). Two days later, significant numbers of SOX9;PDX1
double-positive cells were observed, consistent with the
emergence of mitogenic multipotent ePP cells in vivo (Jen-
nings et al., 2013; Seymour et al., 2007) (Figure S1C). Signif-
icant numbers of HNF1B-, SOX9-, PDX1-, or E-CAD-posi-
tive cells were maintained on day 17, particularly in the
thickened ridges that crisscross the transwell (Figure 1C).
Based on the expression profile of hESC-derived ePP cells
(Figures 1B and S1A), we reasoned that these cells closely
approximate the Pdx1+ dorsal and ventral pancreatic
buds in E9.5 mouse embryos, at a stage prior to the robust
activation of endocrine-commitment genes such as Ngn3
and Nkx6-1 (Ahlgren et al., 1996; Jennings et al., 2013; Jør-
gensen et al., 2007; Offield et al., 1996).
PDX1 Binds a Battery of Foregut/Midgut and Early
Pancreatic Genes in hESC-Derived ePP Cells
PDX1 plays a preeminent, evolutionarily conserved role in
orchestrating pancreatic morphogenesis, but surprisingly
little is known about the identity of its transcriptional
targets during embryonic development. We therefore
combined high-affinity polyclonal PDX1 antibodies with
chromatin immunoprecipitation and deep sequencing
(ChIP-seq) in an effort to uncover those immediate down-
stream genes that govern the early growth and develop-
ment of the human pancreatic anlagen. For these studies,
we selected day 17 of differentiation—a time point that
consistently yielded large numbers (R65%) of PDX1+ ePP
cells (Figure 1D). These analyses revealed 15,436 PDX1-
bound regions that map to 6,212 genes (false discoveryCell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Authors 579
Figure 1. Directed Differentiation of hESCs into Early Pancreatic Progenitors
(A) Schematic of 17-day pancreatic differentiation protocol. On day 2, HES3 cells are plated into fibronectin-coated transwell plates.
Differentiation is initiated on day 0. Growth factors (activin A, BMP4, and FGF2) and small molecules (RA, Nic, and DAPT) were added at the
indicated days (see the Experimental Procedures for additional details). The typical morphological changes that occur during differen-
tiation are shown below the schematic. Scale bar represents 100 mm.
(legend continued on next page)
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Figure 2. PDX1 Binds the Regulatory Re-
gions of Genes Expressed in Foregut/
Midgut Derivatives in hESC-Derived Hu-
man Pancreatic Progenitors
(A) De novo motif analyses identify PDX1,
PBX1, FOXA2, and FOXA1 binding motifs as
the top ranking motifs in PDX1-bound re-
gions identified via ChIP-seq.
(B) Relative frequency of PDX1 binding
events within ±20 kb of the TSS of candi-
date target genes (FDR <10%).
(C) Representative view of PDX1-binding
sites within the PDX1, ONECUT1 (HNF6) and
RFX6 genomic loci.
(D) ChIP-qPCR independently confirms the
presence of PDX1 on regulatory regions of
selected pancreas-related genes. Error bars
indicate the SD of three technical replicates
from a single ChIP-qPCR experiment. These
data were independently confirmed in
repeat pull-down qPCR experiments (data
not shown). Normal goat IgG is the nega-
tive control.
See also Table S1.rate [FDR] < 0.1 with no distance cutoff; Table S1, part A).
The PDX1/PBX1-complex homeodomain-binding motif
was the most highly enriched among the sequence reads,
followed by the FOXA1/FOXA2 forkhead/winged helix
DNA-binding motif (Figure 2A). PBX1 binds 50 to its half-
site ATGATT, whereas PDX1/HOX binds 30 to the half-site
TTAATGG, with an overlap at the middle TT (underlined),
and these proteins heterodimerize to modulate gene tran-
scription (Dutta et al., 2001; Knoepfler et al., 1996; Liu
et al., 2001; Swift et al., 1998). These findings provide
strong evidence that our ChIP-seq data are highly enriched
for specific PDX1 binding events and further suggest that
some PDX1-bound targets in ePP cells are co-regulated by
PBX1 and FOXA proteins.
We next analyzed the binding profile of PDX1 and
observed an increased binding frequency near the TSS of
genes, suggesting that PDX1 plays a major role in tran-(B) Kinetics of endodermal (GATA4), gut tube (HNF1B), and pancreatic
the course of 17 days of differentiation. Error bars represent the SD o
(C) Immunostaining for FOXA2, HNF1B, SOX9, E-CADHERIN, or PDX1 o
100 mm.
(D) Quantitation of PDX1+ pancreatic progenitors by FACS on day 17.
Stemscriptional regulation (Figure 2B); 3,498 PDX1 binding
sites are within ±20 kb of the TSS (FDR < 0.1), correspond-
ing to 2,817 genes (Figure 2B; Table S1, part B). Among
these were genes typically associated with gut endoderm,
specifically the posterior foregut region where Pdx1 shows
localized expression during early mouse pancreatic devel-
opment. These genes include endoderm (CXCR4, LHX1,
GATA4, GATA6), pancreas (MNX1, HNF1B, HNF1A, ONE-
CUT1 (HNF6), PROX1, SOX9, PDX1, MEIS1, RFX6, PAX2,
GLIS3, NR5A2, NKX2-2, SOX4, SOX5, KRT4, KRT18,
KRT19, CPE, IAPP, SLC2A2, PLA2G1B), and numerous
HOX (HOXA1, HOXA2, HOXA3, HOXA4, HOXA6,
HOXB2, HOXC13, HOXD12) genes (Figures 2C and S2A;
Table S1, part B). Genes typically associated with intestinal
development and homeostasis (CDX2, LGR5, DPP4) were
also identified (Figure S2A), which is consistent with the
early expression of Pdx1 in the duodenum and its geneticprogenitor (SOX9, PDX1, HNF6) marker gene expression by qPCR over
f three biological replicates.
n days 10 or 17 of differentiation as indicated. Scale bar represents
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requirement for normal rostral duodenum patterning
(Ahlgren et al., 1996; Guz et al., 1995; Jennings et al.,
2013; Offield et al., 1996). ChIP-qPCR analyses indepen-
dently confirmed several of these binding events (Figures
2D and S2D). Expression analysis also revealed that
HOXA4 and CDX2 levels continuously increased from
day 10 of differentiation onward, paralleling PDX1, while
DPP4 peaked on day 10/12 and then declined (Figures 1B
and S2E).
To gain further insight into the identity of PDX1-bound
target genes, we performed Gene Ontology (GO) analyses.
Statistically significant GO terms included ‘‘developmental
process,’’ ‘‘organ development,’’ ‘‘embryo development,’’
‘‘organ morphogenesis,’’ and ‘‘tube development’’ (Fig-
ure S2B). Genomic Regions Enrichment of Annotations
Tool (GREAT) (http://great.stanford.edu/public/html/
index.php) analysis refined the functional significance of
PDX1-bound regions to GO terms such as ‘‘endocrine
pancreas development’’ and ‘‘columnar/cuboidal epithelial
cell differentiation’’ with the corresponding pathway
designated as ‘‘regulation of gene expression in early
pancreatic precursor cells’’ (Figure S2C). PDX1-bound tar-
gets were also generally associated with genes expressed
in the foregut/midgut region when compared against the
Mouse Genome Informatics (MGI) database (Figure S2C).
Together, these bioinformatics approaches provided
further confidence that PDX1-bound targets in day 17
ePP cells are developmentally relevant to the formation
of the human pancreas.
Candidate PDX1 Transcriptional Targets through
Comparative Microarray Analysis
Microarray analyses performed in quadruplicate on days 0,
10, and 17 of differentiation revealed that these selected
time points corresponded to unique gene expression
signatures (Figure 3A; Table S2, parts A–C). Consistent
with our qPCR studies, numerous pancreas-related genes
were upregulated by day 17, including TM4SF4, MAFB,
CDH1 (E-CAD), SPINK1, PDX1, PROX1, GHRL, RBP4,
RFX6, PCSK2, HOXA2, and HNF1A, whereas several others
such as PITX2, MEIS2, DACH1, ONECUT2, JAG1, FOXA2,
MEIS1, ISL1, SOX9, HNF1B, KRT19, GATA4, GATA6, and
MNX1 were expressed from day 10 onward (Figure 3B).
Pluripotency genes NANOG, OCT4, and SOX2 were pre-
dictably downregulated by day 10, while mesendoderm
(EOMES) and DE (SOX17) genes were downregulated on
day 17 (Figure 3B). The slight increase in SOX2 on day 17
was consistent with the expression of Sox2 in the mouse
anterior foregut (Que et al., 2007) (Figure 3B).
Next, we compared the list of PDX-bound genes to the
day 17 microarray results to identify genes that are poten-
tially directly regulated by PDX1. Among the 2,817 genes
bound by PDX1 (±20 kb from the TSS), 357 were upregu-582 Stem Cell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Autholated, whereas 102 were downregulated on day 17 as
compared with day 0 (Figure 3C; Table S2, parts D and E).
Autoregulation of PDX1 is well documented, and PDX1
was thus as expected among these 357 genes (Table S2,
part D) (Chakrabarti et al., 2002; Marshak et al., 2000).
To home in on key PDX1 targets, we took advantage of
two previously published data sets that attempted to
identify Pdx1-regulated genes in cells or tissue isolated
directly from the developing mouse embryo. In the first,
Pdx-eGFP+ cells were isolated by cell sorting from trans-
genic Pdx1-eGFP E10.5 mouse embryos, and their gene
expression profile determined with Affymetrix microarrays
(Gu et al., 2004). From 56 enrichedmouse genes thus iden-
tified, only 15 human homologs are bound by PDX1 (Fig-
ure 3D; Table S3, part A). These include the DE marker
IGFBP5 and pancreatic regulator MEIS1, as well as a series
of genes poorly characterized for their role in pancreas
growth and development (NR2F1 (COUP-TF1), TNFAIP8,
TANC1, andWSB1 (Figure 3D), all of which show increased
expression on day 17 (Tamplin et al., 2008). Consistent
with its expression in ePP cells (Pan and Wright, 2011;
Shih et al., 2013), Onecut1 (Hnf6) was among the 56
upregulated genes in Pdx1eGFP-sorted cells reported by Gu
et al. (2004). Our results showed that ONECUT1 expression
increased during ePP differentiation (Figure 1B) and
that the ONECUT1 locus was bound by PDX1 (Figures 2C
and 2D).
In a second study, comparative microarrays were per-
formed on microdissected WT and Pdx1/ E10.5 dorsal
pancreatic buds (Svensson et al., 2007). (Beyond this stage,
the unbranched Pdx1/ pancreatic buds growth arrest
and regress [Ahlgren et al., 1996; Offield et al., 1996].)
From 73 genes downregulated in Pdx1 null mutant buds,
20 human homologs were bound by PDX1 (Figure 3E; Ta-
ble S3, part B). Among these 20, 12 showed increased
expression on day 17 and include known endoderm and
pancreas markers (WFDC2, CDH1 (E-CAD), ANXA4,
ITM2B, PARM1), as well as a diverse group of genes whose
functions in pancreas morphogenesis are unknown
(POSTN (PERIOSTIN), SORT1, SPINT2, SERPINB1, and
DYNLT3) (Figure 3E) (Hoffman et al., 2008; Tamplin
et al., 2008). Taken together, these two comparative
studies underscore the developmental significance of
PDX1-bound target genes revealed by our in vitro studies
of differentiating hESCs.
PDX1 is also expressed in adult b cells, and heterozygous
mutations in PDX1 are linked to autosomal dominant early
onset type 2 diabetes (MODY4) (Ohlsson et al., 1993;
Stoffers et al., 1997a).Moreover, inmice, Pdx1 is genetically
required for the maintenance of mature b cell function
(Ahlgren et al., 1998; Gannon et al., 2008). We therefore
asked whether there are common PDX1 gene targets in
day 17 ePP cells and in a recently published study of humanrs
Figure 3. PDX1 Binds and Potentially
Regulates Numerous Developmentally
Important Pancreatic Genes
(A) Microarray gene expression heatmap of
hESCs on days 0, 10, and 17 of pancreatic
differentiation. Each time point is repre-
sented by four biological replicates.
(B) Microarray gene expression heatmap of
selected pluripotency, gastrulation/primi-
tive streak-related, DE, and pancreatic
lineage-related genes from days 0 to 17.
(C) Schematic showing the number of PDX1-
bound genes (±20 kb from the TSS) that
are upregulated and downregulated on day
17 as compared with day 0 (>2-fold; FDR
<0.05).
(D) Of the 56 genes enriched in pancreatic
progenitor cells isolated from the E10.5
mouse embryo (Gu et al., 2004), 15 homo-
logs are bound by PDX1 on day 17 of dif-
ferentiation (2,817 within ± 20 kb from the
TSS). Microarray gene expression heatmap
showing the increase in gene expression of
6 of 15 common targets from days 0 to 17.
The expression of IGFBP5, which encodes an
endodermal marker, peaks at day 5, plum-
mets on day 7, and continually increases
beginning on day 12 by qPCR (data not
shown).
(E) In E10.5 microdissected Pdx1/ E10.5
dorsal pancreatic buds, 73 genes were re-
ported to be significantly downregulated
(Svensson et al., 2007). Of these, 20 ho-
mologs are bound by PDX1 on day 17
of differentiation (2,817 within ±20 kb
from the TSS). Microarray gene expression
heatmap depicting the increase in gene
expression of 12 of 20 common targets from
days 0 to 17 of pancreatic differentiation.
See also Tables S1 and S2.islets harvested from nondiabetic donors (Khoo et al.,
2012).We found 1,096 PDX1-bound genes shared between
the two tissue types (Figure S3A; Table S3, part C) that
GREATclassifies into biological processes such as ‘‘pancreas
development,’’ ‘‘type B pancreatic cell differentiation,’’ and
‘‘endoderm development’’ (Figure S3C). We next identified
the mouse homologs of the 2,817 human genes bound by
PDX1 (±20 kb from TSS) (Figure 3C) and overlapped these
with a more limited ChIP-on-Chip study using the NIT-1
mouse insulinoma cell line (Figure S3B; Table S3, part D)
(Keller et al., 2007). Consistent with a b cell origin of this
cell line, among the 99 shared genes were known b cell reg-
ulators, including MEIS2, NKX2-2, PDX1, TLE1, and TLE3
(Table S3, part D). Taken together, these findings suggestStemthat there is substantial overlap between PDX1 transcrip-
tional targets during development and adult b cell
homeostasis.
PDX1 Binds and Represses Hepatic Genes
In the developing mouse embryo, both explant culture ex-
periments and comprehensive lineage tracing show that
the liver and ventral pancreas arise from bipotent, and
possibly multipotent, precursors in the foregut endoderm
(Angelo et al., 2012; Deutsch et al., 2001; Miki et al.,
2012; Tremblay and Zaret, 2005). Consistent with this tight
lineage relationship, closer inspection of our microarray
data revealed companion upregulation of early liver lineage
genes, including APOA2, TBX3 FOXA1, TTR, AFP, APOB,Cell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Authors 583
HHEX, HNF4A, APOC3, ALB, SERPINA1 (A1AT), and TDO2
on day 17 (Figure 4A). We reasoned that this finding re-
flected the heterogeneous nature of our pancreatic differen-
tiation protocol, unmasking the identity of the roughly
35% PDX1 (Figure 1D), yet endodermally derived cells
present in a given differentiation. We thus confirmed by
qPCR that a series of canonical hepatic markers (FOXA1,
FOXA3, HNF4A, AFP, ALB, TTR, APOA2) were indeed upre-
gulated in an independent differentiation experiment (Fig-
ure S4C). We were surprised to find that PDX1 bound a
number of these genes (±20 kb from the TSS), including
HHEX, FOXA1, FOXA3, TBX3, TTR, AFP, ALB, FABP1,
APOA2, PHKA2, GYS2, ARG1, LEAP2, and CDH17 (Figures
4B and S4A; Table S1, part B). Early Pdx1 expression in
themouse embryo exclusively labels the dorsal and ventral
pancreatic buds, the caudal stomach, bile duct, and rostral
duodenum (Jonsson et al., 1994; Jørgensen et al., 2007; Off-
ield et al., 1996). Recent high-resolution immunohisto-
chemistry and whole-mount in situ hybridization further
demonstrate that Pdx1 and Afp do not co-localize in the
AIP in the early-somite-stage mouse embryo (Miki et al.,
2012). Consistent with this, PDX1 and AFP labeled distinct
cell populations on day 17 of differentiation, with small
nests of AFP+ cells often abutting or near PDX1 labeled
ridges (Figure 4C). This result raises the possibility that a
critical aspect of PDX1 function is to bind and repress he-
patic genes in pancreatic progenitor (PP) cells, ensuring sta-
ble commitment to the pancreatic lineage.
To test this hypothesis, we first asked whether PDX1
overexpression could repress liver genes in the hepatocellu-
lar carcinoma cell line HepG2. We transiently overex-
pressed WT PDX1, or a mutant form of PDX1 (PDX1N196S)
that cannot bindDNA (Horb et al., 2003) and observed sup-
pression of endogenousAFP,ALB,TTR,APOA2, and FOXA1
gene expression by WT, but not PDX1N196S (Figure 4D). In
support of direct repression by PDX1, we confirmed by
ChIP-qPCR that, when overexpressed, WT PDX1 binds
endogenous AFP, ALB, TTR, and FOXA1 regulatory se-
quences (Figure S4B; Table S1, part B). These results show
that the DNA-binding activity of PDX1 is required for its
ability to act as a strong transcriptional repressor when
overexpressed in a terminally differentiated heterologous
cell line.
We next asked whether PDX1 behaved similarly during
hESC differentiation. On day 17, we observed that assorted
liver marker genes were upregulated both by microarray
and qPCR (Figures 4A and S4C). We therefore reasoned
that constitutive overexpression of PDX1 in hESC may
suppress or altogether eliminate the emergence of liver
progenitors alongside ePP cells. Thus, we generated hESC
lines that stably overexpressed either GFP or WT human
PDX1. Importantly, overexpression ofGFP or PDX1neither
impaired pluripotency nor the ability to sequentially acti-584 Stem Cell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Authovate endodermal or pancreatic marker genes (data not
shown; see also Bernardo et al., 2009 and Lavon et al.,
2006).Western analysis revealed that PDX1 almost entirely
suppressed AFP protein expression (Figure 4E), correspond-
ing to a nearly 90% reduction at the mRNA level by qPCR
(Figure 4F). In addition, PDX1 overexpression strongly
suppressed the expression of AFP, ALB, TTR, APOA2, and
FOXA1 (Figure 4F). Taken together, these data suggest
that PDX1 engages a robust commitment to the pancreatic
lineage at least in part by binding the regulatory regions of
liver genes and directly repressing their transcription.DISCUSSION
Given its conspicuous expression in the early pancreatic
anlagen, its ability to directly regulate the Insulin gene pro-
moter and its dramatic loss-of-function phenotype, PDX1
is often designated as ‘‘master regulator’’ of pancreatic
fate (Pan and Wright 2011; Shih et al., 2013). Conse-
quently, numerous studies have attempted to use ectopic
PDX1 to reprogram ‘‘permissive’’ tissues and assorted cell
lines into the pancreatic lineage and, ultimately, functional
beta cells for cell replacement therapy (Meivar-Levy and
Ferber, 2010). For example, adenoviral approaches have
overexpressed either WT PDX1 or an activated PDX1-
VP16 fusion (C-terminal addition of the 80 amino acid
transcriptional activation domain of the Herpes simplex vi-
rus VP16 protein) in the adult mouse liver, an organ whose
embryonic origin is in close proximity to the ventral
pancreas (Angelo et al., 2012; Deutsch et al., 2001; Miki
et al., 2012; Tremblay and Zaret, 2005). Upregulation of
signature pancreatic genes and islet hormones was
observed to varying degrees, and depending on the study,
different criteria were taken as a sign of ‘‘function’’ in the
resulting proto-beta cells, themost stringent being the abil-
ity to positively affect blood glucose levels (Ber et al., 2003;
Ferber et al., 2000; Imai et al., 2005; Kaneto et al., 2005; Ko-
jima et al., 2003). Curiously, these in vivo studies princi-
pally focused on the acquisition of a handful of markers
of pancreatic identity, but not the degree of preservation
or loss of hepatic fate.
PDX1 overexpression experiments provide some evi-
dence that this factor can partially engage the pancreatic
program while conversely suppressing endogenous liver
genes. In studies with primary rodent hepatocytes or liver
epithelial cells, Alb levels were variably downregulated by
overexpressing PDX1 or PDX1-VP16 (Fodor et al., 2007;
Jin et al., 2008; Meivar-Levy et al., 2007; Yamada et al.,
2006). Li et al. (2005) further showed that HepG2 cells
expressing TTR-XlHbox8-VP16, encoding the Xenopus
homolog of PDX1 (XlHbox8) driven by the liver-specific
TTR promoter, activated endocrine genes such as Insulinrs
Figure 4. PDX1 Represses Liver Marker Genes
(A) Microarray gene expression heatmap showing increasing levels of liver lineage-related genes between days 0 and 17 of pancreatic
differentiation.
(B) ChIP-qPCR provides independent confirmation that PDX1 binds in proximity to liver genes. Error bars indicate the SD of three technical
replicates from a single ChIP-qPCR experiment. These data were independently confirmed in repeat pull-down qPCR experiments (data not
shown). Normal goat IgG is the negative control.
(C) AFP and PDX1 immunostaining on day 17 of pancreatic differentiation. AFP and PDX1 label distinct cell populations that are often
observed in close proximity. Scale bar represents 100 mm.
(D) Expression of hepatic genes (AFP, ALB, TTR, APOA2, FOXA1, FOXA2, FOXA3, and HHEX) by qPCR in HepG2 cells after transient over-
expression of GFP, PDX1, or the PDX1(N196S) mutant that cannot bind DNA. Both WT PDX1 and PDX1(N196S) are robustly overexpressed
after transfection. All error bars indicate SD of three biological replicates. For all genes, data are shown relative to the GFP-transfected
controls. p values are indicated.
(E) Western blot analyses for PDX1 and AFP on days 0 and 17 of pancreatic differentiation in GFP- or human PDX1-overexpressing hESC
clones.
(F) Expression of liver markers (AFP, ALB, TTR, APOA2, FOXA1, HHEX) in hESCs stably overexpressing either GFP or human PDX1 and
differentiated for 17 days. Error bars indicate the SD of three biological replicates. p values were calculated when compared with GFP
control.
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and suppressed Alb, Transferrin (Trf), and a-1 anti-trypsin
(Serpin1a) (Li et al., 2005). More akin to our PDX1 overex-
pression experiments in differentiating hESCs, Horb et al.
(2003) reported that transgenic TTR-XlHbox8-VP16 Xeno-
pus tadpoles showed some conversion of liver to pancreas,
scored by reduction of Ttr and activation of Ins, Gcg
and Amylase (Amy) (Horb et al., 2003). This in vivo trans-
differentiation by XlHbox8-VP16 required the XlHbox8
DNA-binding homeodomain, but curiously WT XlHbox8
lacking the VP16 transactivation domain was entirely inef-
fective in ectopically activating pancreatic genes in the
developing liver (Horb et al., 2003). In hESC-derived ePP
cells, we demonstrated by ChIP-seq that WT PDX1 binds
hepatic genes and formally established in HepG2 cells
that such binding is necessary for the direct suppression
of several cardinal liver markers (AFP, ALB, TTR, APOA2,
and FOXA1). Given our ChIP-seq results, one prediction
fromwork in the frog is that the XlHbox8-VP16 fusion pro-
tein should be recruited to and potently activate, rather
than repress, endogenous liver genes. Such a result was
not reported. We posit that the addition of the VP16 mod-
ule so drastically alters WT XlHbox8 (Pdx1) that it is diffi-
cult to compare the results of Horb et al. (2003) with our
own. In addition, the bulk of the studies employing
XlHbox/Pdx1-VP16 fusions did not carefully study tempo-
rally the transdifferentiation of liver to pancreas by assess-
ing the expression of Pdx1-bound hepatic markers (e.g.,
Afp, Ttr, Alb, or Foxa1) at multiple time points, and conse-
quently, one cannot exclude the possibility, ever how un-
likely in our opinion, that an upregulation of hepatic genes
via XlHbox8/Pdx1-VP16 did occur, even transiently. Tak-
ing together these published studies and our own findings,
we favor a model whereby Pdx1-directed ‘‘transdifferentia-
tion’’ of liver to pancreas requires PDX1 to act as both a
transcriptional activator and repressor.
Consistent with our in vitro data, two recent genetic
studies in the mouse provide strong in vivo evidence that
Pdx1 is a bona fide transcriptional repressor. By E11.5,
the pancreatic buds in Pdx1 null mutant embryos arrest
and begin to regress (Ahlgren et al., 1996; Offield et al.,
1996). Recently, Seymour et al. (2012) performed high-res-
olution quantitative immunohistochemistry on Pdx1/
embryos and observed significant numbers of ectopic
Afp+ cells within the dorsal pancreatic bud. This suggestion
of partial conversion to the hepatic cell fate is consistent
with prior work demonstrating that hepatic competence
is not restricted to the region of the ventral foregut where
the liver normally forms (Bossard and Zaret, 1998, 2000;
Gualdi et al., 1996) and with our data that PDX1 represses
AFP in vitro (Figures 4D–4F). Seymour et al. (2012) also
showed that Pdx1 deficiency caused varying degrees of
Sox9 downregulation and that focal loss of Sox9 in the
developing pancreas led to elevated expression of hepatic586 Stem Cell Reports j Vol. 4 j 578–590 j April 14, 2015 j ª2015 The Authomarkers. Our results show that in hESC-derived ePP cells
PDX1 binds SOX9 between exons 2 and 3 (Table S1, part
A), which suggests that SOX9 is positively regulated by
PDX1, as expected for these principal regulators of the
pancreatic program. Phylogenetic sequence conservation
in this region of mouse and human SOX9 genes (data
not shown) fits the idea that this Pdx1-Sox9 regulatory
relationship is central to the pro-pancreatic gene regulato-
ry network. Taken together, these findings indicate that
early-stage Pdx1+ progenitor cells are not stably deter-
mined (‘‘metastable’’), with Pdx1 positively regulating
Sox9 and actively repressing liver potential during a sub-
stantial period of early pancreas organogenesis.
In a second and very recent study, Gao et al. (2014) inac-
tivated Pdx1 in the adult b cell using Cre-Lox methods
with concurrent indelible YFP labeling of the derived
Pdx1/ cells (Gao et al., 2014). Expectedly, these mice
became rapidly hyperglycemic—a result consistent with
prior work (Ahlgren et al., 1998; Gannon et al., 2008)—
but unexpectedly lineage-labeled Pdx1/ cells contained
glucagon and expressed MafB, a transcription factor that
in the adult mouse is restricted to the islet a-cells. These
authors used ChIP from mouse insulinoma cell lines to
detect PDX1 binding within 1.5 kb of theMafB TSS. Taken
together, these findings strongly suggest that Pdx1 directly
represses MafB transcription in adult b cells. Interestingly,
MafB is required for the production of both a and b cells
during pancreas development, but its expression is extin-
guished in b cells soon after birth (Hang and Stein,
2011). Consistent with this in vivo expression kinetic,
we observed MAFB levels increasing from days 0 to 17 of
hESC differentiation (Figure 3B). However, MAFB tran-
scriptional regulation is apparently independent of PDX1
at these stages, as PDX1 binding was observed a great dis-
tance from the MAFB TSS (R150 kb) (Table S1, part A). In
addition, it is important to highlight recent data showing
that, in contrast to mice, MAFB persists in a subset of hu-
man adult b cells (9%) (Dai et al., 2012). This finding sug-
gests that in mice Pdx1 adopts its role as a transcription
repressor late in b cell ontogeny and that in humans
PDX1+MAFB+ and PDX1+MAFB represent distinct b cell
subtypes.
Our findings raise an important outstanding question:
what is the mechanism underlying PDX1 transcriptional
repression? We speculate that one answer lies in the top-
ranking motifs enriched in our ChIP-seq data—PBX1 and
FOXA1/A2. Nearly 20 years ago, Pdx1 was shown to bind
the HOX-cofactor Pbx1 (pre-B cell leukemia factor 1), a
member of the TALE (three-amino-acid loop extension)
familyof atypicalhomeodomain-containingproteins (Peers
et al., 1995). Pbx1 alternative splicing yields two isoforms
differing at their C termini, the longer Pbx1a and shorter
Pbx1b. Pdx1:Pbx1b complexes transcriptionally activaters
target genes, while Pdx1:Pbx1a forms a repressor complex
through the recruitment of co-repressor proteins such as
NCoR-SMRT (or HDAC) (Asahara et al., 1999; Saleh et al.,
2000). PBX1A and PBX1B are both expressed during human
ePP differentiation (Figure S1A; A.K.K.T. andN.R.D., unpub-
lished data), raising the possibility of differential recruit-
ment within the same cell to activate or repress appropriate
gene targets to direct lineage choice and stabilization. Simi-
larly, FOXA transcription factors can also recruit HDAC via
the co-repressor Groucho-related protein 3 (Grg3; formally
Tle3), which is highly expressed in the pancreas during
embryonic development, to silence genes central to hepatic
differentiation (Lam et al., 2013; Santisteban et al., 2010).
Our data also show that FOXA1/A2binding siteswere signif-
icantly enriched in sequence reads fromday 17 PDX1ChIP-
seq (Figure 2A), and FOXA2:PDX1 co-binding was observed
frequently in nearly 2,000 loci in mouse islets (Hoffman
et al., 2010). Canonical FOXA1/A2 motifs exist close
to PDX1 binding in both AFP and TTR, also suggesting
context-dependent functions of FOXA proteins. Finally,
it is important to note that approximately 100 genes are
bound by PDX1 on day 17, but their expression is signifi-
cantly downregulated by microarray (comparing day 17 to
day 0) (Figure 3C; Table S2, part E). Obvious candidates for
direct repression among these100 include FGF8,TWIST2,
ETV4, and ZIC3, whose mouse orthologs are typically
expressed in mesoderm or mesodermally derived tissues
during embryonic development (http://www.informatics.
jax.org/genes.shtml) (Table S2, part E). Methods to address
the issue of direct repression or activation of PDX1 target
loci include the development of PDX1-deficient hESC lines
or lines carrying inducible knockdown tools for context and
time-dependent inactivation.EXPERIMENTAL PROCEDURES
Cell Culture
HES3 (ESO3; http://www.nationalstemcellbank.org) were cultured
on g-irradiated human Ortec feeders in hESC medium supple-
mented with 50-ng/ml FGF2 or in mTeSR 1 medium (STEMCELL
Technologies) (Teo et al., 2012). Colonies were passaged every
7 days by treating with 1-mg/ml collagenase IV followed by fine
scoring with a pipet tip. HepG2 cells (ATCC) were cultured in
DMEM high glucose (Invitrogen), 10% fetal bovine serum (FBS),
and 2-mM L-glutamine.
Transfection
Human PDX1 cDNA was cloned into pTP6. The N196S point mu-
tationwas introduced using theDirectedMutagenesis kit (Agilent).
Transfection of HepG2 and HES3 cells was performed with Lipo-
fectamine 2000 (Invitrogen); 4 mg of pTP6-hPDX1 and pTP6-
hPDX1N196S were transfected into HepG2 cells for 48 hr followed
by selection in puromycin (2 mg/ml) for 6 days. Similarly, 4 mg of
pTP6-hPDX1 was transfected into HES3 cells and 1 mg/ml of puro-Stemmycin was included in the hESC medium for 1 week to select for
hPDX1-overexpressing HES3 lines.
Pancreatic Differentiation
Feeder cells were depleted using a 70-mm cell strainer (BD Falcon)
prior to directed differentiation (Teo et al., 2012). hESCs were
plated onto fibronectin-coated transwell plates (Corning) and
cultured in hESC medium for 2 days. They were induced to differ-
entiate in RPMI-1640, 2% B-27, 2-mM L-glutamine, 55-mM b-mer-
captoethanol, and 1 3 MEM NEAA medium supplemented with
50-ng/ml activin A and 50-ng/ml BMP4 for 3 days followed by 2
additional days in 50 ng/ml activin A (schematized in Figure 1A).
Cultures were then exposed to 50-ng/ml FGF2, 3-mM all-trans-
RA, and 10-mM nicotinamide (Nic) for 5 days; 50-ng/ml FGF2, 3-
mM RA, 10-mM Nic, and 20-mM DAPT for 4 days; and 50-ng/ml
FGF2, 10-mM Nic, and 20-mM DAPT for 3 days.
qPCR, Western Blot, Immunostaining, FACS, ChIP-
Seq, and Microarray Hybridization and Data Analyses
Methods for qPCR, western blot, immunostaining, FACS, ChIP-
seq, and microarray analyses were previously described (Teo
et al., 2012; Tsuneyoshi et al., 2012). More detailed methods for
ChIP-seq,microarray hybridization, and data analysis are provided
in the Supplemental Experimental Procedures. Primers and anti-
bodies are listed in Table S4.
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Procedures, four figures, and four tables and can be found with
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